![Test Utilization: Payment Policies More Effective than Practice Recommendations in Curbing Orders of Low-Value Tests](https://www.g2intelligence.com/wp-content/uploads/2023/04/56181_G2_stock_6-1080x675.jpg)
Test Utilization: Payment Policies More Effective than Practice Recommendations in Curbing Orders of Low-Value Tests
...
...
...
...
In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning
...